As early as the 1920s, and subsequently in the 1959 Build and Blood Pressure Study (S1. 5-
1) of almost 5 million adults insured between 1934 and 1954, a strong direct relationship …

Hypertension in renal transplant recipients is common and ranges from 50% to 80% in adult
recipients and from 47% to 82% in pediatric recipients. Cardiovascular morbidity and …

The original KDIGO Clinical Practice Guideline for the Management of Blood Pressure in
Chronic Kidney Disease in the chronic kidney disease (CKD) population not receiving …

Solid organ transplantation (SOT) is an established therapeutic option for chronic disease
resulting from end-stage organ dysfunction. Long-term use of immunosuppression is …

Post-transplantation diabetes mellitus (PTDM) may severely impact both short-and long-term
outcomes of kidney transplant recipients in terms of graft and patient survival. However …

Carboxylesterase 1 (CES1) is the major hydrolase in human liver. The enzyme is involved in
the metabolism of several important therapeutic agents, drugs of abuse, and endogenous …

Hypertension is common in kidney transplantation recipients and may be difficult to treat.
Factors present before kidney transplantation, related to the transplantation procedure itself …

In nontransplant populations, effects of different antihypertensive drug classes vary. Relative
effects in kidney transplant recipients are uncertain. We performed a systematic review …

Abstract Purpose of Review This review is intended to briefly describe the primary
mechanistic pathways by which several common drugs can increase blood pressure. We …

Kidney transplantation is considered the treatment of choice for end-stage kidney disease
patients. However, the residual cardiovascular risk remains significantly higher in kidney …